The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Biologic profile to predict overall survival in non-metastatic breast cancer: A latent class analysis on aging biomarkers.
 
Claire Falandry
Honoraria - Astellas Oncology; AstraZeneca; BMS GmbH & Co. KG; Chugai Pharma; GlaxoSmithKline; Lilly O.; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - Chugai Pharma; Clovis Oncology; Eisai; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - Bayer; GlaxoSmithKline; Pfizer; Viatris
 
Barbara Anna Henk Brouwers
No Relationships to Disclose
 
Cindy Kenis
No Relationships to Disclose
 
Ann Smeets
No Relationships to Disclose
 
Patrick Neven
Consulting or Advisory Role - Lilly (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Radius Health (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly (Inst); Pfizer (Inst); Roche (Inst)
 
Charlotte Cuerq
No Relationships to Disclose
 
Karim Chikh
No Relationships to Disclose
 
Sigrid Hatse
No Relationships to Disclose
 
Hans Wildiers
Honoraria - MSD (Inst)
Consulting or Advisory Role - AstraZeneca (Inst); Astrazeneca (Inst); Augustine Therapeutics (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo Europe GmbH (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Immutep (Inst); Lilly (Inst); Lilly (Inst); MSD (Inst); Parexel (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Lilly (Inst); Gilead Sciences (Inst); Roche (Inst)